Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 11, 2017, Pages 1684-1697.e11

  Iannone, Andrea ^a   Ruospo, Marinella ^b,d   Wong, Germaine ^e,f   Principi, Mariabeatrice ^a   Barone, Michele ^a   Strippoli, Giovanni F M ^a,b,c,e   Di Leo, Alfredo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Diaverum Medical Scientific Office   (Sweden)

^c Diaverum   (Sweden)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e UNIVERSITY OF SYDNEY   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

i SCAN; NBI; Surveillance

Indexed keywords

ADVERSE EVENT; ALL CAUSE MORTALITY; CANCER MORTALITY; CHROMOENDOSCOPY; CLINICAL OUTCOME; COLON BIOPSY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SURVEILLANCE; GASTROINTESTINAL DYSPLASIA; HISTOLOGY; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TIME; ULCERATIVE COLITIS; WHITE LIGHT ENDOSCOPY; COLORECTAL TUMOR; COMPLICATION; DIAGNOSTIC TEST; EARLY CANCER DIAGNOSIS; ENDOSCOPY; EVALUATION STUDY; PROCEDURES;

COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; ENDOSCOPY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 85037858034     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.11.021     Document Type: Review

References (53)

1. Jess, T., Rungoe, C., Peyrin-Biroulet, L., Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10 (2012), 639–645.
2. Jess, T., Gamborg, M., Matzen, P., et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100 (2005), 2724–2729.
3. Jess, T., Frisch, M., Simonsen, J., Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 11 (2013), 43–48.
4. Rutter, M., Saunders, B., Wilkinson, K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004), 451–459.
5. Gupta, R.B., Harpaz, N., Itzkowitz, S., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133 (2007), 1099–1105.
6. Loughrey, M.B., Shepherd, N.A., The pathology of bowel cancer screening. Histopathology 66 (2015), 66–77.
7. Farraye, F.A., Odze, R.D., Eaden, J., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138 (2010), 738–745.
8. American Society for Gastrointestinal Endoscopy Standards of Practice Committee, Shergill, A.K., Lightdale, J.R., et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 81 (2015), 1101–1121.
9. Annese, V., Daperno, M., Rutter, M.D., et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 7 (2013), 982–1018.
10. European Crohn's and Colitis Organisation. ECCO e-guide. Colorectal carcinoma surveillance, ulcerative colitis. Available from: http://www.e-guide.ecco-ibd.eu/interventions-investigational/colorectal-carcinoma-surveillance#ulcerative-colitis. Accessed: October 8, 2016.
11. Connell W, Kamm M, Kench J, et al. Cancer Council Australia Surveillance Colonoscopy Guidelines Working Party. Clinical practice guidelines for Surveillance Colonoscopy. Sydney: Cancer Council Australia. Available from: http://wiki.cancer.org.au/australia/Guidelines:Colorectal_cancer/Colonoscopy_surveillance. Accessed: October 8, 2016.
12. Howdle, P., Atkin, W., Rutter, M., Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas. National Institute for Health and Clinical Excellence (NICE) Clinical guideline. 2011, National Institute for Health and Clinical Excellence, London.
13. Kamiński, M.F., Hassan, C., Bisschops, R., et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 46 (2014), 435–449.
14. Itzkowitz, S.H., Present, D.H., Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11 (2005), 314–321.
15. Lichtenstein, G.R., Hanauer, S.B., Sandborn, W.J., et al. Management of Crohn's disease in adults. Am J Gastroenterol 104 (2009), 465–483.
16. Collins, P.D., Mpofu, C., Watson, A.J., et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev, 2, 2006, CD000279.
17. Rubin, C.E., Haggitt, R.C., Burmer, G.C., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103 (1992), 1611–1620.
18. Rubin, D.T., Rothe, J.A., Hetzel, J.T., et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?. Gastrointest Endosc 65 (2007), 998–1004.
19. East, J.E., Colonoscopic cancer surveillance in inflammatory bowel disease: what's new beyond random biopsy?. Clin Endosc 45 (2012), 274–277.
20. Subramanian, V., Ramappa, V., Telakis, E., et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 19 (2013), 350–355.
21. Laine, L., Kaltenbach, T., Barkun, A., et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81 (2015), 489–501.
22. Dekker, E., van den Broek, F.J., Reitsma, J.B., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 39 (2007), 216–221.
23. Leifeld, L., Rogler, G., Stallmach, A., et al. White-light or narrow-band imaging colonoscopy in surveillance of ulcerative colitis: a prospective multicenter study. Clin Gastroenterol Hepatol 13 (2015), 1776–1781.
24. van den Broek, F.J., Fockens, P., van Eeden, S., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 57 (2008), 1083–1089.
25. van den Broek, F.J., Fockens, P., van Eeden, S., et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 43 (2011), 108–115.
26. Ignjatovic, A., East, J.E., Subramanian, V., et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 107 (2012), 885–890.
27. Iacucci, M., Fort Gasia, M., Akinola, O., et al. Final results of a randomized study comparing high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. Gastroenterology, 150, 2016, S129.
28. Wu, L., Li, P., Wu, J., et al. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trial. Colorectal Dis 14 (2012), 416–420.
29. Konijeti, G.G., Shrime, M.G., Ananthakrishnan, A.N., et al. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc 79 (2014), 455–465.
30. Subramanian, V., Mannath, J., Ragunath, K., et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 33 (2011), 304–312.
31. Mowat, C., Cole, A., Windsor, A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 60 (2011), 571–607.
32. European Crohn's and Colitis Organisation. ECCO e-guide. Colorectal carcinoma surveillance, Crohn's disease. Available from: http://www.e-guide.ecco-ibd.eu/interventions-investigational/colorectal-carcinoma-surveillance#crohnsdisease. Accessed: October 8, 2016.
33. Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269 W64.
34. Magro, F., Langner, C., Driessen, A., et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7 (2013), 827–851.
35. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58 (2003), S3–S43.
36. Schlemper, R.J., Riddell, R.H., Kato, Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 (2000), 251–255.
37. Rubio, C.A., Nesi, G., Messerini, L., et al. Serrated and microtubular colorectal adenomas in Italian patients. A 5-year survey. Anticancer Res 25 (2005), 1353–1359.
38. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
39. Higgins, J.P., Thompson, S.G., Deeks, J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
40. Kiesslich, R., Fritsch, J., Holtmann, M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124 (2003), 880–888.
41. Kiesslich, R., Goetz, M., Lammersdorf, K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132 (2007), 874–882.
42. Feitosa, F., Carlos, A., Guilherme Nogueira, J., et al. Narrow-band imaging and chromoendoscopy for the detection of colonic dysplasia in inflammatory bowel disease: a prospective and randomized study. Inflamm Bowel Dis 17 (2011), S14–S15.
43. Pellisé, M., López-Cerón, M., Rodríguez de Miguel, C., et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 74 (2011), 840–848.
44. Bisschops, R., Bessissow, T., Baert, F.J., et al. Chromo-endoscopy versus narrow band imaging in ulcerative colitis: a prospective randomized controlled trial. Gastrointest Endosc, 75, 2012, AB148.
45. Freire, P., Figueiredo, P., Cardoso, R., et al. Surveillance in ulcerative colitis: is chromoendoscopy-guided endomicroscopy always better than conventional colonoscopy? A randomized trial. Inflamm Bowel Dis 20 (2014), 2038–2045.
46. Mohammed, N., Kant, P., Abid, F., et al. High definition white light endoscopy (Hdwle) versus high definition with chromoendoscopy (Hdce) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc, 81, 2015, AB148.
47. Park, S.J., Kim, H.S., Yang, D.H., et al. High definition chromoendoscopy with water-jet versus high definition white light endoscopy in the detection of dysplasia in long standing ulcerative colitis: a multicenter prospective randomized controlled study. Gastroenterology, 150, 2016, S1270.
48. Watanabe, K., Nishishita, M., Shimamoto, F., et al. Comparison between newly-developed narrow band imaging and panchromoendoscopy for surveillance colonoscopy in patients with longstanding ulcerative colitis: a prospective multicenter randomized controlled trial, navigator study. Gastrointest Endosc, 83, 2016, AB172.
49. Subramanian, V., Ragunath, K., Advanced endoscopic imaging: a review of commercially available technologies. Clin Gastroenterol Hepatol 12 (2014), 368–376.
50. Omata, F., Ohde, S., Deshpande, G.A., et al. Image-enhanced, chromo, and cap-assisted colonoscopy for improving adenoma/neoplasia detection rate: a systematic review and meta-analysis. Scand J Gastroenterol 49 (2014), 222–237.
51. Davies, J., Burke, D., Olliver, J.R., et al. Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy. Gut 56 (2007), 155–156.
52. ® tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples - a single center, open label, safety, phase II study. Gastroenterology 148 (2015), S827–S828.
53. Rath, T., Tontini, G.E., Vieth, M., et al. In vivo real-time assessment of colorectal polyp histology using an optical biopsy forceps system based on laser-induced fluorescence spectroscopy. Endoscopy 48 (2016), 557–562.